Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
2,560.24
2,497.47
2,285.92
2,751.62
2,518.62
2,395.54
2,343.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,560.24
2,497.47
2,285.92
2,751.62
2,518.62
2,395.54
2,343.93
Raw Material Cost
1,547.12
1,541.93
1,411.62
1,606.87
1,454.38
1,381.86
1,439.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.65
2.83
3.04
2.89
1.87
1.56
1.21
Selling and Distribution Expenses
618.96
673.67
678.18
665.49
624.67
616.55
630.22
Other Expenses
-0.26
-0.28
-0.30
-0.29
-0.19
-0.16
6.78
Total Expenditure (Excl Depreciation)
2,166.08
2,215.60
2,089.80
2,272.37
2,079.06
1,998.41
2,138.73
Operating Profit (PBDIT) excl Other Income
394.20000000000005
281.90000000000003
196.1
479.3
439.6
397.1
205.2
Other Income
0.99
2.32
-0.86
1.21
-0.08
1.24
2.65
Operating Profit (PBDIT)
457.59
346.59
253.34
541.54
497.12
454.18
266.08
Interest
2.65
2.83
3.04
2.89
1.87
1.56
1.21
Exceptional Items
0.05
0.71
1.61
0.57
0.83
1.19
-8.04
Gross Profit (PBDT)
1,013.12
955.54
874.30
1,144.75
1,064.23
1,013.68
904.42
Depreciation
62.44
62.40
58.09
61.07
57.64
55.80
58.23
Profit Before Tax
392.56
282.08
193.83
478.15
438.44
398.00
198.62
Tax
96.18
66.56
53.49
129.69
119.17
108.45
98.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
296.38
215.51
140.34
348.46
319.27
289.55
100.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
296.38
215.51
140.34
348.46
319.27
289.55
100.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
296.38
215.51
140.34
348.46
319.27
289.55
100.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
7,625.68
7,329.30
7,515.99
7,376.06
7,286.36
6,967.28
7,022.47
Earnings per share (EPS)
10.32
7.5
4.88
12.13
11.11
10.08
3.5
Diluted Earnings per share
10.32
7.5
4.88
12.13
11.11
10.08
3.5
Operating Profit Margin (Excl OI)
15.4%
11.29%
8.58%
17.42%
17.45%
16.58%
8.75%
Gross Profit Margin
17.77%
13.79%
11.02%
19.6%
19.7%
18.94%
10.96%
PAT Margin
11.58%
8.63%
6.14%
12.66%
12.68%
12.09%
4.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 1.65% vs 2.27% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -7.17% vs 9.01% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -8.17% vs 8.46% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 36.84% vs 58.33% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Daiken Medical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(JPY)
Change(%)
Net Sales
2,560.24
69,177.91
-66,617.67
-96.30%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,560.24
69,177.91
-66,617.67
-96.30%
Raw Material Cost
1,547.12
61,191.84
-59,644.72
-97.47%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.65
48.41
-45.76
-94.53%
Selling and Distribution Expenses
618.96
8,137.48
-7,518.52
-92.39%
Other Expenses
-0.26
-4.84
4.58
94.63%
Total Expenditure (Excl Depreciation)
2,166.08
69,329.32
-67,163.24
-96.88%
Operating Profit (PBDIT) excl Other Income
394.16
-151.41
545.57
360.33%
Other Income
0.99
352.30
-351.31
-99.72%
Operating Profit (PBDIT)
457.59
804.93
-347.34
-43.15%
Interest
2.65
48.41
-45.76
-94.53%
Exceptional Items
0.05
-43.90
43.95
100.11%
Gross Profit (PBDT)
1,013.12
7,986.07
-6,972.95
-87.31%
Depreciation
62.44
604.04
-541.60
-89.66%
Profit Before Tax
392.56
-33.07
425.63
1,287.06%
Tax
96.18
-37.74
133.92
354.85%
Provisions and contingencies
0
0
0.00
Profit After Tax
296.38
4.67
291.71
6,246.47%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
296.38
4.67
291.71
6,246.47%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
296.38
4.67
291.71
6,246.47%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
7,625.68
20,478.13
-12,852.45
-62.76%
Earnings per share (EPS)
10.32
0.16
10.16
6,350.00%
Diluted Earnings per share
10.32
0.16
10.16
6,350.00%
Operating Profit Margin (Excl OI)
15.40%
-0.22%
0.00
15.62%
Gross Profit Margin
17.77%
0.83%
0.00
16.94%
PAT Margin
11.58%
0.01%
0.00
11.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 256.02 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 2.51% vs 9.26% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1.65% vs 2.27% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 29.64 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 37.54% vs 53.60% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -7.17% vs 9.01% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 45.66 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 32.62% vs 35.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -8.17% vs 8.46% in Sep 2024
Quarterly - Interest
Interest 0.26 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -7.14% vs -6.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 36.84% vs 58.33% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.40%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
